{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:37:05Z","timestamp":1761709025712},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,19]],"date-time":"2014-11-19T00:00:00Z","timestamp":1416355200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12967-014-0315-x","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T20:04:57Z","timestamp":1416341097000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hepatoprotective and antioxidant activities of extracts from Salvia\u2014Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice"],"prefix":"10.1186","volume":"12","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanchen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangbing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,19]]},"reference":[{"key":"315_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","volume":"53","author":"V Ratziu","year":"2010","unstructured":"Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G: A position statement on NAFLD\/NASH based on the EASL 2009 special conference. J Hepatol. 2010, 53: 372-384. 10.1016\/j.jhep.2010.04.008.","journal-title":"J Hepatol"},{"key":"315_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA: Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011, 140: 124-131. 10.1053\/j.gastro.2010.09.038.","journal-title":"Gastroenterology"},{"key":"315_CR3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1204265","volume":"332","author":"JC Cohen","year":"2011","unstructured":"Cohen JC, Horton JD, Hobbs HH: Human fatty liver disease: old questions and new insights. Science. 2011, 332: 1519-1523. 10.1126\/science.1204265.","journal-title":"Science"},{"key":"315_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.dld.2009.01.004","volume":"41","author":"S Petta","year":"2009","unstructured":"Petta S, Muratore C, Craxi A: Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis. 2009, 41: 615-625. 10.1016\/j.dld.2009.01.004.","journal-title":"Dig Liver Dis"},{"key":"315_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1582-4934.2002.tb00518.x","volume":"6","author":"CP Oliveira","year":"2002","unstructured":"Oliveira CP, da Costa Gayotto LC, Tatai C, Della Bina BI, Janiszewski M, Lima ES, Abdalla DS, Lopasso FP, Laurindo FR, Laudanna AA: Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J Cell Mol Med. 2002, 6: 399-406. 10.1111\/j.1582-4934.2002.tb00518.x.","journal-title":"J Cell Mol Med"},{"key":"315_CR6","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","volume":"35","author":"J Aubert","year":"2011","unstructured":"Aubert J, Begriche K, Knockaert L, Robin MA, Fromenty B: Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. Clin Res Hepatol Gastroenterol. 2011, 35: 630-637. 10.1016\/j.clinre.2011.04.015.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"315_CR7","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/S0140-6736(99)00163-4","volume":"353","author":"O James","year":"1999","unstructured":"James O, Day C: Non-alcoholic steatohepatitis: another disease of affluence. Lancet. 1999, 353: 1634-1636. 10.1016\/S0140-6736(99)00163-4.","journal-title":"Lancet"},{"key":"315_CR8","doi-asserted-by":"crossref","first-page":"G1135","DOI":"10.1152\/ajpgi.2001.281.5.G1135","volume":"281","author":"G Robertson","year":"2001","unstructured":"Robertson G, Leclercq I, Farrell GC: Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol. 2001, 281: G1135-G1139.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"315_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0168-8278(00)80120-8","volume":"33","author":"O Niemela","year":"2000","unstructured":"Niemela O, Parkkila S, Juvonen RO, Viitala K, Gelboin HV, Pasanen M: Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. J Hepatol. 2000, 33: 893-901. 10.1016\/S0168-8278(00)80120-8.","journal-title":"J Hepatol"},{"key":"315_CR10","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1128\/MCB.01658-12","volume":"33","author":"J He","year":"2013","unstructured":"He J, Hu B, Shi X, Weidert ER, Lu P, Xu M, Huang M, Kelley EE, Xie W: Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3. Mol Cell Biol. 2013, 33: 2047-2055. 10.1128\/MCB.01658-12.","journal-title":"Mol Cell Biol"},{"key":"315_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-2004-823104","volume":"24","author":"IR Wanless","year":"2004","unstructured":"Wanless IR, Shiota K: The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis. 2004, 24: 99-106. 10.1055\/s-2004-823104.","journal-title":"Semin Liver Dis"},{"key":"315_CR12","first-page":"2714","volume":"97","author":"SA Harrison","year":"2002","unstructured":"Harrison SA, Kadakia S, Lang KA, Schenker S: Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol. 2002, 97: 2714-2724.","journal-title":"Am J Gastroenterol"},{"key":"315_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2005.09.002","volume":"44","author":"H Cortez-Pinto","year":"2006","unstructured":"Cortez-Pinto H, de Moura MC, Day CP: Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol. 2006, 44: 197-208. 10.1016\/j.jhep.2005.09.002.","journal-title":"J Hepatol"},{"key":"315_CR14","first-page":"S1","volume":"20","author":"CA Dinarello","year":"2002","unstructured":"Dinarello CA: The IL-1 family and inflammatory diseases. Clin Exp Rheumatol. 2002, 20: S1-S13.","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 3","key":"315_CR15","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1186\/ar576","volume":"4","author":"JS Pober","year":"2002","unstructured":"Pober JS: Endothelial activation: intracellular signaling pathways. Arthritis Res. 2002, 4 (Suppl 3): S109-S116. 10.1186\/ar576.","journal-title":"Arthritis Res"},{"key":"315_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/MPG.0b013e3181c7bdf1","volume":"50","author":"A Alisi","year":"2010","unstructured":"Alisi A, Manco M, Devito R, Piemonte F, Nobili V: Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2010, 50: 645-649. 10.1097\/MPG.0b013e3181c7bdf1.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"315_CR17","doi-asserted-by":"publisher","first-page":"22341","DOI":"10.1074\/jbc.M010839200","volume":"276","author":"YP Han","year":"2001","unstructured":"Han YP, Tuan TL, Hughes M, Wu H, Garner WL: Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem. 2001, 276: 22341-22350. 10.1074\/jbc.M010839200.","journal-title":"J Biol Chem"},{"key":"315_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00109-009-0464-1","volume":"87","author":"M Malaguarnera","year":"2009","unstructured":"Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L: Molecular mechanisms involved in NAFLD progression. J Mol Med. 2009, 87: 679-695. 10.1007\/s00109-009-0464-1.","journal-title":"J Mol Med"},{"key":"315_CR19","first-page":"560","volume":"118","author":"BK Popivanova","year":"2008","unstructured":"Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N: Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest. 2008, 118: 560-570.","journal-title":"J Clin Invest"},{"key":"315_CR20","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3945\/jn.112.165274","volume":"142","author":"E Marcolin","year":"2012","unstructured":"Marcolin E, San-Miguel B, Vallejo D, Tieppo J, Marroni N, Gonzalez-Gallego J, Tunon MJ: Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. J Nutr. 2012, 142: 1821-1828. 10.3945\/jn.112.165274.","journal-title":"J Nutr"},{"key":"315_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3736\/jintegrmed2013034","volume":"11","author":"HY Song","year":"2013","unstructured":"Song HY, Zhang L, Pan JL, Yang LL, Ji G: Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis. J Integr Med. 2013, 11: 262-268. 10.3736\/jintegrmed2013034.","journal-title":"J Integr Med"},{"key":"315_CR22","first-page":"942","volume":"25","author":"ZS Ma","year":"2007","unstructured":"Ma ZS, Liu T, Zheng PY, Xing LJ, Ji G: Effect of Chinese Medicine Jiangzhi Granula on Hepaticlipid of Nonalcoholic Fatty Liver Disease Rats. Chin Arch Tradit Chin Med. 2007, 25: 942-944.","journal-title":"Chin Arch Tradit Chin Med"},{"key":"315_CR23","first-page":"965723","volume":"2013","author":"J Pan","year":"2013","unstructured":"Pan J, Wang M, Song H, Wang L, Ji G: The efficacy and safety of traditional chinese medicine (jiang zhi granule) for nonalcoholic Fatty liver: a multicenter, randomized, placebo-controlled study. Evidence-based Complement Altern Med: eCAM. 2013, 2013: 965723-","journal-title":"Evidence-based Complement Altern Med: eCAM"},{"key":"315_CR24","first-page":"88","volume":"19","author":"L Zhang","year":"2009","unstructured":"Zhang L, Liu T, Wang M, Xing LJ, Ji G, Zheng PY: Effect of Jiang zhi granula on leptin and leptin receptor of hypothalamus in rats with nonalcoholic liver disease. Chin J Integr Tradit West Med Liver Dis. 2009, 19: 88-91.","journal-title":"Chin J Integr Tradit West Med Liver Dis"},{"key":"315_CR25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.11569\/wcjd.v17.i8.753","volume":"17","author":"PY Zheng","year":"2009","unstructured":"Zheng PY, Zhang L, Liu T, Wang M, Xing LJ, Ji G: Effect of Jiangzhi granule on STAT3 expression in hypothalamus of rats with nonalcoholic fatty liver disease. World Chin J Digestol. 2009, 17: 753-757.","journal-title":"World Chin J Digestol"},{"key":"315_CR26","first-page":"584634","volume":"2013","author":"M Wang","year":"2013","unstructured":"Wang M, Sun S, Wu T, Zhang L, Song H, Hao W, Zheng P, Xing L, Ji G: Inhibition of LXRalpha\/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule. Evidence-based Complement Altern Med: eCAM. 2013, 2013: 584634-","journal-title":"Evidence-based Complement Altern Med: eCAM"},{"key":"315_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12967-014-0236-8","volume":"12","author":"L Zhang","year":"2014","unstructured":"Zhang L, Xu J, Song H, Yao Z, Ji G: Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity. J Transl Med. 2014, 12: 236-10.1186\/s12967-014-0236-8.","journal-title":"J Transl Med"},{"key":"315_CR28","first-page":"449","volume":"8","author":"YL Lu","year":"2010","unstructured":"Lu YL, Wang M, Zhang L, He YQ, Yang L, Wang CH, Wang ZT, Ji G: Simultaneous determination of six components in the `Jiang-Zhi granule by UPLC-MS analysis. Chin J Nat Med. 2010, 8: 449-455.","journal-title":"Chin J Nat Med"},{"key":"315_CR29","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1172\/JCI8814","volume":"105","author":"IA Leclercq","year":"2000","unstructured":"Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR: CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest. 2000, 105: 1067-1075. 10.1172\/JCI8814.","journal-title":"J Clin Invest"},{"key":"315_CR30","unstructured":"National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals., Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.): Guide for the care and use of laboratory animals. 8th edn. Washington, D.C.: National Academies Press; 2011."},{"key":"315_CR31","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, Network NCR: Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011, 53: 810-820. 10.1002\/hep.24127.","journal-title":"Hepatology"},{"key":"315_CR32","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.3945\/jn.108.091009","volume":"138","author":"Y Wang","year":"2008","unstructured":"Wang Y, Ausman LM, Russell RM, Greenberg AS, Wang XD: Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. J Nutr. 2008, 138: 1866-1871. 10.3945\/jn.108.091009.","journal-title":"J Nutr"},{"key":"315_CR33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0004-28032011000100015","volume":"48","author":"E Marcolin","year":"2011","unstructured":"Marcolin E, Forgiarini LF, Tieppo J, Dias AS, Freitas LA, Marroni NP: Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis. Arq Gastroenterol. 2011, 48: 72-79.","journal-title":"Arq Gastroenterol"},{"key":"315_CR34","first-page":"171","volume":"24","author":"N Phung","year":"2009","unstructured":"Phung N, Pera N, Farrell G, Leclercq I, Hou JY, George J: Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis. Int J Mol Med. 2009, 24: 171-180.","journal-title":"Int J Mol Med"},{"key":"315_CR35","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0168-8278(03)00376-3","volume":"39","author":"J George","year":"2003","unstructured":"George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G: Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol. 2003, 39: 756-764. 10.1016\/S0168-8278(03)00376-3.","journal-title":"J Hepatol"},{"key":"315_CR36","first-page":"233","volume":"8","author":"JG Fan","year":"2009","unstructured":"Fan JG, Qiao L: Commonly used animal models of non-alcoholic steatohepatitis. Hepatobiliary Pancreat Dis Int. 2009, 8: 233-240.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"315_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000282097","volume":"28","author":"JM Schattenberg","year":"2010","unstructured":"Schattenberg JM, Galle PR: Animal models of non-alcoholic steatohepatitis: of mice and man. Dig Dis. 2010, 28: 247-254. 10.1159\/000282097.","journal-title":"Dig Dis"},{"key":"315_CR38","doi-asserted-by":"crossref","unstructured":"London RM, George J: Pathogenesis of NASH: animal models.Clinics in liver disease 2007, 11:55-74, viii.,","DOI":"10.1016\/j.cld.2007.02.010"},{"key":"315_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.lfs.2011.11.012","volume":"90","author":"AK Min","year":"2012","unstructured":"Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK: Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL\/6 mice. Life Sci. 2012, 90: 200-205. 10.1016\/j.lfs.2011.11.012.","journal-title":"Life Sci"},{"key":"315_CR40","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/0960327113485253","volume":"32","author":"HJ Park","year":"2013","unstructured":"Park HJ, Han JM, Kim HG, Choi MK, Lee JS, Lee HW, Son CG: Chunggan extract (CGX), methionine-and choline-deficient (MCD) diet-induced hepatosteatosis and oxidative stress in C57BL\/6 mice. Hum Exp Toxicol. 2013, 32: 1258-1269. 10.1177\/0960327113485253.","journal-title":"Hum Exp Toxicol"},{"key":"315_CR41","doi-asserted-by":"publisher","first-page":"31S","DOI":"10.1016\/0002-9343(91)90281-2","volume":"91","author":"H Sies","year":"1991","unstructured":"Sies H: Oxidative stress: from basic research to clinical application. Am J Med. 1991, 91: 31S-38S. 10.1016\/0002-9343(91)90281-2.","journal-title":"Am J Med"},{"key":"315_CR42","first-page":"57","volume":"34","author":"M Koruk","year":"2004","unstructured":"Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M: Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci. 2004, 34: 57-62.","journal-title":"Ann Clin Lab Sci"},{"key":"315_CR43","doi-asserted-by":"crossref","unstructured":"Koek GH, Liedorp PR, Bast A: The role of oxidative stress in non-alcoholic steatohepatitis.Clin Chim Acta 2011, 412:1297-1305.,","DOI":"10.1016\/j.cca.2011.04.013"},{"key":"315_CR44","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/j.1572-0241.2004.30159.x","volume":"99","author":"N Chalasani","year":"2004","unstructured":"Chalasani N, Deeg MA, Crabb DW: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2004, 99: 1497-1502. 10.1111\/j.1572-0241.2004.30159.x.","journal-title":"Am J Gastroenterol"},{"key":"315_CR45","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0168-8278(01)00192-1","volume":"35","author":"C Loguercio","year":"2001","unstructured":"Loguercio C, De Girolamo V, de Sio I, Tuccillo C, Ascione A, Baldi F, Budillon G, Cimino L, Di Carlo A, Di Marino MP, Morisco F, Picciotto F, Terracciano L, Vecchione R, Verde V, Del Vecchio Blanco C: Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol. 2001, 35: 568-574. 10.1016\/S0168-8278(01)00192-1.","journal-title":"J Hepatol"},{"key":"315_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hepres.2003.08.001","volume":"28","author":"CS Lieber","year":"2004","unstructured":"Lieber CS: CYP2E1: from ASH to NASH. Hepatology research: the official journal of the Japan Society of Hepatology. 2004, 28: 1-11. 10.1016\/j.hepres.2003.08.001.","journal-title":"Hepatology research: the official journal of the Japan Society of Hepatology"},{"key":"315_CR47","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jhep.2012.05.019","volume":"57","author":"MA Abdelmegeed","year":"2012","unstructured":"Abdelmegeed MA, Banerjee A, Yoo SH, Jang S, Gonzalez FJ, Song BJ: Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. J Hepatol. 2012, 57: 860-866. 10.1016\/j.jhep.2012.05.019.","journal-title":"J Hepatol"},{"key":"315_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/hep.21004","volume":"43","author":"P Gong","year":"2006","unstructured":"Gong P, Cederbaum AI: Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology. 2006, 43: 144-153. 10.1002\/hep.21004.","journal-title":"Hepatology"},{"key":"315_CR49","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.taap.2010.03.016","volume":"245","author":"YK Zhang","year":"2010","unstructured":"Zhang YK, Yeager RL, Tanaka Y, Klaassen CD: Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet. Toxicol Appl Pharmacol. 2010, 245: 326-334. 10.1016\/j.taap.2010.03.016.","journal-title":"Toxicol Appl Pharmacol"},{"key":"315_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2009.11.007","volume":"48","author":"S Chowdhry","year":"2010","unstructured":"Chowdhry S, Nazmy MH, Meakin PJ, Dinkova-Kostova AT, Walsh SV, Tsujita T, Dillon JF, Ashford ML, Hayes JD: Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic Biol Med. 2010, 48: 357-371. 10.1016\/j.freeradbiomed.2009.11.007.","journal-title":"Free Radic Biol Med"},{"key":"315_CR51","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00702-013-0982-4","volume":"120","author":"P Orsu","year":"2013","unstructured":"Orsu P, Murthy BV, Akula A: Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats. J Neural Transm. 2013, 120: 1217-1223. 10.1007\/s00702-013-0982-4.","journal-title":"J Neural Transm"},{"key":"315_CR52","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s12035-013-8559-7","volume":"49","author":"HK Moghaddam","year":"2014","unstructured":"Moghaddam HK, Baluchnejadmojarad T, Roghani M, Khaksari M, Norouzi P, Ahooie M, Mahboobi F: Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats. Mol Neurobiol. 2014, 49: 820-826. 10.1007\/s12035-013-8559-7.","journal-title":"Mol Neurobiol"},{"key":"315_CR53","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1089\/jmf.2012.0175","volume":"16","author":"R Domitrovic","year":"2013","unstructured":"Domitrovic R, Jakovac H, Marchesi VV, Blazekovic B: Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl(4)-intoxicated mice is mediated by suppression of oxidative stress and upregulation of MMP-2 expression. J Med Food. 2013, 16: 518-528. 10.1089\/jmf.2012.0175.","journal-title":"J Med Food"},{"key":"315_CR54","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","volume":"125","author":"AE Feldstein","year":"2003","unstructured":"Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ: Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology. 2003, 125: 437-443. 10.1016\/S0016-5085(03)00907-7.","journal-title":"Gastroenterology"},{"key":"315_CR55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/hep.20999","volume":"43","author":"JM Schattenberg","year":"2006","unstructured":"Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ: JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology. 2006, 43: 163-172. 10.1002\/hep.20999.","journal-title":"Hepatology"},{"key":"315_CR56","doi-asserted-by":"publisher","first-page":"8469","DOI":"10.1128\/MCB.19.12.8469","volume":"19","author":"K Yamamoto","year":"1999","unstructured":"Yamamoto K, Ichijo H, Korsmeyer SJ: BCL-2 is phosphorylated and inactivated by an ASK1\/Jun N-terminal protein kinase pathway normally activated at G(2)\/M. Mol Cell Biol. 1999, 19: 8469-8478.","journal-title":"Mol Cell Biol"},{"key":"315_CR57","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.1059108","volume":"292","author":"MC Wei","year":"2001","unstructured":"Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001, 292: 727-730. 10.1126\/science.1059108.","journal-title":"Science"},{"key":"315_CR58","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/ijerph7051872","volume":"7","author":"A Miranda-Mendez","year":"2010","unstructured":"Miranda-Mendez A, Lugo-Baruqui A, Armendariz-Borunda J: Molecular basis and current treatment for alcoholic liver disease. Int J Environ Res Public Health. 2010, 7: 1872-1888. 10.3390\/ijerph7051872.","journal-title":"Int J Environ Res Public Health"},{"key":"315_CR59","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1002\/lt.21336","volume":"13","author":"CP Day","year":"2007","unstructured":"Day CP: Treatment of alcoholic liver disease. Liver Transpl. 2007, 13: S69-S75. 10.1002\/lt.21336.","journal-title":"Liver Transpl"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-014-0315-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-014-0315-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-014-0315-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-014-0315-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:29:26Z","timestamp":1630564166000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-014-0315-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,19]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1186\/s12967-014-0315-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,19]]},"assertion":[{"value":"13 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"315"}}